Hassan Fred 13D/13G Filings for Cocrystal Pharma, Inc. (COCP)

Hassan Fred 13D and 13G filings for Cocrystal Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-04-12
4:09 pm
Purchase
2023-04-0413GCocrystal Pharma, Inc.
COCP
Hassan Fred1,015,229
10.000%
1,015,229increase
(New Position)
Filing